Sihuan Pharmaceutical Holdings Group (HKSE:00460) Change In Working Capital : HK$122 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group Change In Working Capital?

Sihuan Pharmaceutical Holdings Group's change in working capital for the quarter that ended in Dec. 2023 was HK$354 Mil.

Sihuan Pharmaceutical Holdings Group's change in working capital for the fiscal year that ended in Dec. 2023 was HK$122 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Sihuan Pharmaceutical Holdings Group Change In Working Capital Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group Change In Working Capital Chart

Sihuan Pharmaceutical Holdings Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

184.47

-486.05

-301.87

162.37

121.52

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															25.37	67.52	98.04	-232.95	354.47

Sihuan Pharmaceutical Holdings Group Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$122 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Sihuan Pharmaceutical Holdings Group Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sihuan Pharmaceutical Holdings Group (HKSE:00460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (HKSE:00460) » Definitions » Change In Working Capital

Traded in Other Exchanges

SHPHF:USA

Address

Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025

Website

https://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.

Executives

Che Fengsheng	2201 Interest of corporation controlled by you
Guo Weicheng	2201 Interest of corporation controlled by you
Meng Xianhui	2201 Interest of corporation controlled by you
Zhang Jionglong	2201 Interest of corporation controlled by you
Mingyao Capital Limited	2401 A concert party to an agreement to buy shares
Network Victory Limited	2401 A concert party to an agreement to buy shares
Proper Process International Limited	2401 A concert party to an agreement to buy shares
Successmax Global Holdings Limited	2101 Beneficial owner
Victory Faith International Limited	2401 A concert party to an agreement to buy shares
Ubs Tc (jersey) Ltd	2301 Trustee
Ubs Trustees (cayman) Ltd.	2301 Trustee
Smart Top Overseas Limited	2501 Other
Plenty Gold Enterprises Limited	2307 Founder of a discretionary trust who can infl

Sihuan Pharmaceutical Holdings Group (HKSE:00460) Headlines

No Headlines